CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Cash flows from operating activities:
Net loss	$ (4,268)	$ (171)
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization of deferred acquisition costs	16,645	16,440
Acquisition costs deferred	(17,637)	(18,009)
Realized investment gains, net	(1,210)	(70)
Unrealized losses on equity securities, net	1,516	2,177
Losses from equity method investees	766	360
Compensation expense related to share awards	11	119
(Benefit) provision for credit losses	(26)	26
Depreciation and amortization	366	652
Deferred income tax benefit	(1,747)	(3,121)
Increase in receivables, net	(5,581)	(3,520)
Increase in insurance reserves and policyholder funds	12,684	9,771
Increase (decrease) in accounts payable and accrued expenses	6,137	(1,662)
Other, net	(2,856)	(370)
Net cash provided by operating activities	4,800	2,622
Cash flows from investing activities:
Proceeds from investments sold and policy loans redeemed	2,567	5,044
Proceeds from investments matured, called or redeemed	13,791	9,744
Investments purchased	(13,850)	(18,073)
Additions to property and equipment	(225)	(80)
Net cash provided by (used in) investing activities	2,283	(3,365)
Cash flows from financing activities:
Payment of dividends on Series D preferred stock	(399)	(399)
Payment of dividends on common stock	(408)	(408)
Treasury stock acquired - net employee share-based compensation	(7)	(12)
Proceeds from revolving credit facility, net	1,000	1,000
Net cash provided by financing activities	186	181
Net increase (decrease) in cash	7,269	(562)
Cash and cash equivalents at beginning of year	28,301	28,863
Cash and cash equivalents at end of year	35,570	28,301
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest	3,445	3,227
Cash paid for income taxes	$ 580	$ 2,582